N
This company uses proprietary AI, combining large language models with evolutionary optimization, to design optimized protein and peptide variants digitally. They focus on improving properties like affinity, stability, and immunogenicity based on a parental amino acid sequence input. The service delivers a small set of highly optimized candidates for lab validation, accelerating therapeutic discovery cycles.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- This company uses proprietary AI, combining large language models with evolutionary optimization, to design optimized protein and peptide variants digitally. They focus on improving properties like affinity, stability, and immunogenicity based on a parental amino acid sequence input. The service delivers a small set of highly optimized candidates for lab validation, accelerating therapeutic discovery cycles.